These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32373692)

  • 1. Worsening cytology and lesion enlargement are useful indicators for malignant transformation of lobular endocervical glandular hyperplasia during follow-up: A case report.
    Kobara H; Miyamoto T; Otsuki T; Ohya A; Shiozawa T
    Gynecol Oncol Rep; 2020 May; 32():100571. PubMed ID: 32373692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of adenocarcinoma in situ arising in lobular endocervical glandular hyperplasia indicating localization of mucin on the cluster surface as an early cytological finding of malignant transformation.
    Okuyama R; Hashimoto H; Miura T; Sugita M; Arai M; Tsunoda H; Sasajima Y; Horiuchi H
    Diagn Cytopathol; 2017 Sep; 45(9):842-847. PubMed ID: 28449203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology and management of lobular endocervical glandular hyperplasia.
    Miyamoto T; Kobara H; Shiozawa T
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3056-3067. PubMed ID: 36177810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative differential diagnosis of minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia of the uterine cervix: a multicenter study of clinicopathology and magnetic resonance imaging findings.
    Takatsu A; Shiozawa T; Miyamoto T; Kurosawa K; Kashima H; Yamada T; Kaku T; Mikami Y; Kiyokawa T; Tsuda H; Ishii K; Togashi K; Koyama T; Fujinaga Y; Kadoya M; Hashi A; Susumu N; Konishi I
    Int J Gynecol Cancer; 2011 Oct; 21(7):1287-96. PubMed ID: 21685796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited frequency of malignant change in lobular endocervical glandular hyperplasia.
    Kobara H; Miyamoto T; Ando H; Asaka R; Takatsu A; Ohya A; Asaka S; Shiozawa T
    Int J Gynecol Cancer; 2020 Oct; 30(10):1480-1487. PubMed ID: 32883699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranuclear cytoplasmic inclusion is a significant diagnostic feature for the differentiation of lobular endocervical glandular hyperplasia from minimal deviation adenocarcinoma of the cervix.
    Hashi A; Yuminamochi T; Xu JY; Kondo T; Katoh R; Hoshi K
    Diagn Cytopathol; 2008 Aug; 36(8):535-44. PubMed ID: 18618730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case of minimal deviation adenocarcinoma: possible clinical link to lobular endocervical glandular hyperplasia as its origin.
    Sugihara T; Nakagawa S; Sasajima Y; Matsumoto Y; Takeshita S; Ayabe T
    J Obstet Gynaecol Res; 2015 Mar; 41(3):483-7. PubMed ID: 25257165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of a management protocol for patients with cervical multicystic lesions: A retrospective analysis of 94 cases and the significance of GNAS mutation.
    Ando H; Miyamoto T; Kashima H; Takatsu A; Ishii K; Fujinaga Y; Shiozawa T
    J Obstet Gynaecol Res; 2016 Nov; 42(11):1588-1598. PubMed ID: 27718288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of endocervical minimal deviation adenocarcinoma with varicolored cytopathologic features on Pap smear.
    Omori M; Kondo T; Nakazawa K; Shinohara S; Watanabe Y; Fukasawa H; Nakazawa T; Hashi A; Hirata S
    Diagn Cytopathol; 2018 Aug; 46(8):702-706. PubMed ID: 29573230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic Cytological Findings of Lobular Endocervical Glandular Hyperplasia Associated with Adenocarcinoma of the Uterine Cervix.
    Ishii S; Ito T; Yamada M; Yamazaki N; Ikebata K; Fujiyama J; Furuta N; Komatsu K; Takeuchi K; Sugiyama Y; Takazawa Y
    Acta Cytol; 2020; 64(6):556-562. PubMed ID: 32814324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminant Analysis Using Gabor Filter Sets for Lobular Endocervical Glandular Hyperplasia: Numerical Interpretation of Nuclear Atypia by Gabor Filter Features.
    Kimura F; Ohshima K; Shirai K; Kanai R; Sonohara M; Ishii K
    Acta Cytol; 2023; 67(5):539-549. PubMed ID: 37497898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study.
    Kawauchi S; Kusuda T; Liu XP; Suehiro Y; Kaku T; Mikami Y; Takeshita M; Nakao M; Chochi Y; Sasaki K
    Am J Surg Pathol; 2008 Dec; 32(12):1807-15. PubMed ID: 18779726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type.
    Yamanoi K; Ishii K; Tsukamoto M; Asaka S; Nakayama J
    Virchows Arch; 2018 Sep; 473(3):305-311. PubMed ID: 29845361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteria.
    Tsuda H; Mikami Y; Kaku T; Hasegawa T; Akiyama F; Ohishi Y; Sasajima Y; Kasamatsu T
    Pathol Int; 2005 Jul; 55(7):412-8. PubMed ID: 15982216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminant analysis and interpretation of nuclear chromatin distribution and coarseness using gray-level co-occurrence matrix features for lobular endocervical glandular hyperplasia.
    Kanai R; Ohshima K; Ishii K; Sonohara M; Ishikawa M; Yamaguchi M; Ohtani Y; Kobayashi Y; Ota H; Kimura F
    Diagn Cytopathol; 2020 Aug; 48(8):724-735. PubMed ID: 32374944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of gastric-type adenocarcinoma of the uterine cervix associated with lobular endocervical glandular hyperplasia: radiologic-pathologic correlation.
    Tsuboyama T; Yamamoto K; Nakai G; Yamada T; Fujiwara S; Terai Y; Ohmichi M; Narumi Y
    Abdom Imaging; 2015 Mar; 40(3):459-65. PubMed ID: 25504516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions.
    Mikami Y; McCluggage WG
    Adv Anat Pathol; 2013 Jul; 20(4):227-37. PubMed ID: 23752085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonality analysis suggests that STK11 gene mutations are involved in progression of lobular endocervical glandular hyperplasia (LEGH) to minimal deviation adenocarcinoma (MDA).
    Takatsu A; Miyamoto T; Fuseya C; Suzuki A; Kashima H; Horiuchi A; Ishii K; Shiozawa T
    Virchows Arch; 2013 Jun; 462(6):645-51. PubMed ID: 23645358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia: a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining.
    Mikami Y; Kiyokawa T; Moriya T; Sasano H
    Histopathology; 2005 Feb; 46(2):130-6. PubMed ID: 15693884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image quantification technology of the heterochromatin and euchromatin region for differential diagnosis in the lobular endocervical glandular hyperplasia.
    Kimura F; Kobayashi T; Kanai R; Kobayashi Y; Yuhi O; Ota H; Yamaguchi M; Yokokawa Y; Uehara T; Ishii K
    Diagn Cytopathol; 2019 Jun; 47(6):553-563. PubMed ID: 30761780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.